HPV legislation in New York
Contents
Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" [1]:
POPULATION: 19,306,183
Incidence & Mortality (2008 Score / 2007 Score)
- Cervical Cancer Incidence Rate: 8.5/100,000 (1/ 1)
- Cervical Cancer Incidence Rate/Race: White: 7.5, Black: 12.1, Hispanic: 11.9, Asian/Pacific Islander: 6.6
- Cervical Cancer Mortality Rate: 2.4/100,000 (1 / 1)
- Cervical Cancer Mortality Rate/Race: White: 2.3, Black: 3.7, Hispanic: 3.1, Asian/Pacific Islander: 2.0
Screening (2008 Score / 2007 Score)
- Cervical Cancer Screening Rate: 85.1% (1 / 1)
- Cervical Cancer Screening Rate/Race: White: 85.6%, Black: 86.8%, Hispanic: 88.3%
- % Uninsured/Unscreened: 22.9% (1 / 1)
- Medicaid Coverage HPV Testing: Unrestricted (2 / 2)
Healthcare Access (2008 Score / 2007 Score)
- Rate Uninsured Women: 16% (1 / 1)
- % Low Income/Uninsured Women: 29%
Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)
Screening Requirements (0 / 1)
- There are no new screening requirements.
Task Forces (2 / 2)
- There is no new cervical cancer prevention task force legislation.
Access to HPV Vaccines (1 / 1)
- SB 4394/AB 5810 provides for the immunization of all children born after Jan. 1, 1996, with the HPV vaccine; sent to Senate/Assembly Committees on Health.
- AB 7403 encourages voluntary, informed vaccination against HPV for school-aged children; sent to Assembly Committee on Health.
- AB 8536/AB 6296/SB 5629/SB 4172 would require insurance companies to provide coverage for the HPV vaccine; sent to Assembly/Senate Insurance Committees.
HPV Vaccine Information Programs (0 / 0)
- There is no HPV vaccine information activity.
Miscellaneous (1 / 2)
- AB 7148 grants four hours of excused leave to public officers and employees of NY State to undertake screening for cervical cancer; passed Assembly, sent to Senate Rules Committee.
- AB 2856/SB 1342 would establish an age-appropriate sexuality education grant program within the Dept. of Health; would include information on the HPV vaccine; passed Assembly, referred to Senate Health Committee.
Annual Ratings
- 2008: Good (13 out of 22 points)
- 2007: Very Good (12 out of 18 points)
Articles and resources
SourceWatch Resources
- Gardasil
- GlaxoSmithKline
- Merck
- Women in Government
- Edelman
- The Marketing of Gardasil in Australia
- The Marketing of Gardasil in Canada
- The Marketing of Gardasil in Europe
- The Marketing of Gardasil in New Zealand
- The Marketing of Gardasil in the United States
- Direct-to-consumer advertising
- Disease Mongering
- Drug industry
External links
- Judith Siers-Poisson, The Politics and PR of Cervical Cancer, a four part series, PRWatch.org, July, 2007.
References
- ↑ "The 'State' of Cervical Cancer Prevention in America - 2008", Women in Government